Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07525921

Immediate Effect of Dry Needling on Calf Muscles Pain Pressure Threshold,Sprint Speed and Functional Performance in Amateur Football Player

This randomised single-blind trial will evaluate the immediate effect of a single session of dry needling versus sham needling on calf muscle myofascial trigger points among amateur football players aged 18-25 years. Primary and secondary outcomes are Pressure Pain Threshold (algometer), Sprint Speed (shuttle run test), and Functional Performance (single-leg hop). Outcomes will be measured immediately pre- and post-intervention. Data analysis will be performed in SPSS version 27 using paired and independent t-tests (p < 0.05).

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Myofascial Pain Syndromes Gastrocnemius Muscle Muscular Diseases Musculoskeletal Diseases Trigger Points

Age range

18 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Foundation University College of Physical Therapy

Islamabad, Punjab Province, 46000, Pakistan

Location status: Recruiting

Location contact

Hamza Aliyan, DPT

CONTACT

[email protected]

03209092006

About this study

A randomised, single-blind, parallel-group trial recruiting amateur club football players (age 18-25) with active myofascial trigger points in gastrocnemius or soleus. Participants randomised (coin toss) into Group A (Dry Needling) or Group B (Sham Needling). Baseline measures: Pressure Pain Threshold (PPT) using handheld algometer, ankle dorsiflexion ROM with goniometer, sprint speed via shuttle run, and single-leg hop distance. Intervention: a single session of dry needling (sterile single-use filiform needles 0.25-0.30 mm; needles retained ~10 minutes with fast-in/fast-out pistoning to elicit local twitch response) or a non-penetrating sham procedure mimicking needling. Post-intervention assessments are performed immediately after the session. Data will be analysed with SPSS v.27; paired t-tests for within-group and independent t-tests for between-group comparisons (p < 0.05).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Amateur football players aged 18-25 years.

Participation in club-level football for at least one year.

Presence of active myofascial trigger point in gastrocnemius or soleus confirmed by palpation.

Willingness to participate and provide informed consent.

Exclusion criteria

  • History of calf muscle tear, fracture, or lower limb surgery.

Current use of muscle relaxants or anti-inflammatory medication.

Known bleeding disorders or anticoagulant therapy.

Local infection, skin lesion, or contraindication to dry needling.

Neurological or vascular disorders affecting lower limb function.

Treatment and study plan

dry needling

Procedure

A single-session myofascial trigger point dry needling treatment will be administered to identified trigger points in the gastrocnemius and/or soleus muscles using sterile disposable filiform needles. The objective is to mechanically disrupt the dysfunctional motor end plate, elicit local twitch responses, reduce nociceptive activity, and restore muscle function. The intervention is delivered under aseptic conditions by a trained physiotherapist following standard safety guidelines. Post-procedure monitoring will be conducted for minor adverse effects such as soreness or bleeding.

Sham needling

Procedure

A simulated needling procedure designed to act as a placebo comparator will be applied without skin penetration. The technique reproduces the visual, tactile, and contextual components of dry needling to maintain participant blinding while avoiding physiological stimulation of the muscle. This allows isolation of the true therapeutic effect of dry needling from psychological or expectancy-related responses.

Other names: Placebo Needling

Primary outcomes

  1. Pain Pressure Threshold

    Time frame: Baseline (Day 0, pre-intervention) and Immediately Post-intervention (within 15 minutes after intervention).

    Pressure Pain Threshold will be measured at the identified myofascial trigger point in the gastrocnemius or soleus using a handheld pressure algometer. The participant will indicate the point at which applied pressure first becomes painful. The recorded value (kg/cm²) reflects mechanical pain sensitivity of the trigger point.

  2. Functional Performance

    Time frame: Baseline (Day 0, pre-intervention) and Immediately Post-intervention (within 15 minutes after intervention).

    Functional performance will be assessed using Single leg hop test ( distance in centimeters).The Single Leg Hop Test measures lower limb explosive power. Participants will perform three maximal forward hops on one leg. The distance (in centimeters) from the starting line to the heel landing point will be recorded. The average of three trials will be used for analysis. Greater distance indicates improved functional performance.

  3. Sprint Speed

    Time frame: Baseline (Day 0, pre-intervention) and Immediately Post-intervention (within 15 minutes after intervention).

    Sprint speed will be accessed by Shuttle run test. The speed and agility of lower limb in calf muscle by time taken to complete a short distance shuttle sprint. It reflects the explosive function of calf muscle which is essential for acceleration and direction change in football.

    Sprint speed will be assessed using a 20-meter shuttle run test. Participants will run back and forth between two markers placed 20 meters apart as quickly as possible. Two trials will be performed, and the fastest time (in seconds) will be recorded to the nearest 0.1 second. Lower time indicates better sprint performance.

Secondary outcomes

  1. Range of Motion of Ankle Dorsiflexion

    Time frame: Baseline (Day 0, pre-intervention) and Immediately Post-intervention (within 15 minutes after intervention).

    Ankle dorsiflexion will be measured in degrees using a universal goniometer. Three readings will be taken and averaged. Higher degrees indicate improved flexibility.

Study contacts

Contact information is provided by the study sponsor or research team.

Hamza Aliyan, DPT

CONTACT

[email protected]

03209092006

Marwa Asim, MS-OMPT

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Foundation University Islamabad

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 13, 2026
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.